About: Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal disease. The company is based in Bala Cynwyd, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Latest price: $2.64 (+3.94%)
LRMR NASDAQ Larimar Therapeutics Inc
Carregando status da lista de acompanhamento…
Larimar Therapeutics Inc share price
Atividade de preço de LRMR
Último preço
$ 2,640
Variação (24h)
0,10 USD (3,94%)
Volume
658.03K
Volume (média 4 sem.)
-
Abertura
$ 2,57
Variação do dia
$ 2,56 - $ 2,73
Fechamento anterior
$ 2,54
Último negócio
29 Oct, 6:32 pm GMT+0
Atrasado
29 Oct, 6:32 pm GMT+0
LRMR price performance
+16,30%
5D
-15,92%
1M
-30,71%
YTD
-38,75%
1Y
Atrasado
29 Oct, 6:32 pm GMT+0
quote.marketSignals